| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/02/2003 | EP1073647A4 12,13-cyclopropane epothilone derivatives |
| 01/02/2003 | EP1052993B1 Combination of an alpha-adrenergic antagonist and a nitrogen oxide donor for treating female sexual dysfunction |
| 01/02/2003 | EP1019374B1 Polymorphs of donepezil hydrochloride and process for production |
| 01/02/2003 | EP1019370B1 Ace-inhibitor nitric salts |
| 01/02/2003 | EP0992241B1 Medicinal compositions against helicobacter pylori |
| 01/02/2003 | EP0989989B1 13-dihydro-3'aziridino anthracyclines |
| 01/02/2003 | EP0980383B1 Pharmaceutically acceptable salts of 3-hydroxy-estr-5(10)-en-17-one 3-sulphate active as estrogens |
| 01/02/2003 | EP0980382B1 Estrogenic 19-norandrost-17-one derivatives with an aromatic b-ring |
| 01/02/2003 | EP0942714B1 A product, a method for its production, and its use |
| 01/02/2003 | EP0937718B1 Antibiotic tkr2648 and process for producing the same |
| 01/02/2003 | EP0934265B1 Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof |
| 01/02/2003 | EP0928195B1 Compositions for use in embolizing blood vessels |
| 01/02/2003 | EP0925286B1 Substituted pyrimidine derivatives and their pharmaceutical use |
| 01/02/2003 | EP0915859B1 Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands |
| 01/02/2003 | EP0910386B1 Combinations comprising vx478, zidovudine and 1592u89 for use in the treatment of hiv |
| 01/02/2003 | EP0893999B8 Process for producing efonidipine hydrochloride preparations |
| 01/02/2003 | EP0885244B1 Peptide immunogens for vaccination against and treatment of allergy |
| 01/02/2003 | EP0883401B1 At1 receptor antagonist for the stimulation of apoptosis |
| 01/02/2003 | EP0863754B1 Hydrolysis-optimized lipid emulsions and use thereof |
| 01/02/2003 | EP0828727B1 Cyclohexyl dihydrobenzofuranes |
| 01/02/2003 | EP0804431B9 GLYCOPROTEIN IIb/IIIa ANTAGONISTS |
| 01/02/2003 | EP0754457B1 Antiobestic agent |
| 01/02/2003 | EP0751939B9 Naphthylamides as central nervous system agents |
| 01/02/2003 | EP0745131B1 Targeting gene therapy |
| 01/02/2003 | EP0723440B1 Therapeutic delivery compositions and methods of use thereof |
| 01/02/2003 | EP0705245B1 Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives |
| 01/02/2003 | EP0630366B1 Substituted heterocyclic derivatives useful as platelet aggregation inhibitors |
| 01/02/2003 | CA2414726A1 Bicyclic lactams and sulfonamides with 5-ht1a-affinity and use thereof for preventing and treating cerebral ischaemia |
| 01/02/2003 | CA2391753A1 Combination chemotherapy |
| 01/01/2003 | CN1388808A Thermosensitive cyclotriphosphazene-platinum complex conjugate, its preparation method and anticancer agent containing the same |
| 01/01/2003 | CN1388760A Hyaluronan as a cytotoxic agent, drug pre-sensitizer and chemo-sensitizer in the treatment of disease |
| 01/01/2003 | CN1388759A Medicine containing Anemonin as effective component for treating aseptic inflammation |
| 01/01/2003 | CN1388758A Pharmaceutical compositions of anti-tubercular drugs and process for their preparation |
| 01/01/2003 | CN1388757A Bioavailable dosage form of isotretinoin |
| 01/01/2003 | CN1388129A Extraction process of chlorhematin as iron-replenishing agent |
| 01/01/2003 | CN1388126A 吡咯并三嗪和嘧啶化合物 Pyrrolo-triazine and pyrimidine compounds |
| 01/01/2003 | CN1388120A Intermediate used as new industrial products in preparation of new cephalosporin containing sbstituted benzyloxy imino on 7-position |
| 01/01/2003 | CN1388118A Substituted phenyl alkyl nitrogen monoxide synthase inhibitor and its prepn and use |
| 01/01/2003 | CN1387899A Externally applied ointment for treating burns and its prepn |
| 01/01/2003 | CN1387896A Compound seabuckthorn fruit oil suppository |
| 01/01/2003 | CN1387888A Chinese medicine prepn for resisting osteoporosis |
| 01/01/2003 | CN1387868A Prepn process and new use of general asiaticoside |
| 01/01/2003 | CN1387858A Prepn of high-selectivity heavy metal lead repellent |
| 01/01/2003 | CN1387857A Fibroblast growth promoter and its application |
| 01/01/2003 | CN1387856A Medicine for resisting ischemia and re-infusion damage |
| 01/01/2003 | CN1387855A Licorice polysaccharide powder injection |
| 01/01/2003 | CN1387854A Dispersed general arasaponin tablet and its prepn and application |
| 01/01/2003 | CN1387853A Externally applied compound antifungal prepn |
| 01/01/2003 | CN1387852A Compound stomatocase-treating capsule |
| 01/01/2003 | CN1387851A Nasal cavity administrated prepn for treating cerebral tumor |
| 01/01/2003 | CN1387850A 复方东莨菪碱 Compound scopolamine |
| 01/01/2003 | CN1387849A Use of thiazolidinedione for preventing or retaining non-insulin-dependent diabets mellitus (NIDDM) attack |
| 01/01/2003 | CN1387848A Use of thiazolidinedione for preventing or retaining non-insulin-dependent diabets mellitus (NIDDM) attack |
| 01/01/2003 | CN1387847A Lefunomide plaster and its prepn |
| 01/01/2003 | CN1387846A Intraocular pressure reducing agent |
| 01/01/2003 | CN1387845A Medicinal composition for treating autoimmune disease |
| 01/01/2003 | CN1387844A Wide-spectrum externally applied venereal remedy |
| 01/01/2003 | CN1387843A Medicine for preventing and treating osteoporosis |
| 01/01/2003 | CN1387842A Transdermal plaster of aryl propionic non-steroid antiphlogistic |
| 01/01/2003 | CN1097588C Dihydrobenzofuran and related compounds used as anti-inflammatory agents |
| 01/01/2003 | CN1097587C Dihydrobenzofuran and related compound used as anti-inflammatory agent |
| 01/01/2003 | CN1097580C Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes |
| 01/01/2003 | CN1097579C Ortho-substituted benzoylguanidines, process for their preparation, use and medicine containing them |
| 01/01/2003 | CN1097462C Internally applied veterinary drug for treating pig's parasitosis |
| 01/01/2003 | CN1097460C Amino sugar and related sugar derivatives of cytotoxic of indolopyrro locarbazoles |
| 01/01/2003 | CN1097459C Diazepino-indoles as phosphodiesterase IV inhibitors |
| 01/01/2003 | CN1097458C Stable oil-in-water emulsions containing taxine (taxol) and its producing process |
| 01/01/2003 | CN1097457C Treatment and prevention of untoward effect to reactive oxygen component |
| 01/01/2003 | CN1097456C Method for manufacturing troche for eliminating gastrointestinal vesicle and its application |
| 01/01/2003 | CN1097455C New aqueous medicament preparation for the production of propellent gas-free acrosols |
| 12/31/2002 | WO2002002117A1 Therapeutic or preventive medicines for mood disorders or anxiety disorders |
| 12/31/2002 | USRE37947 Aromatic polyenic compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 12/31/2002 | US6500987 Sertraline hydrochloride polymorphs |
| 12/31/2002 | US6500959 Pyrrolidine derivatives and processes for preparing same |
| 12/31/2002 | US6500945 Nucleotides having chiral phosphorus linkages |
| 12/31/2002 | US6500936 Glycerol culture of actinomyces |
| 12/31/2002 | US6500930 Hemoglobin-polysaccharide conjugates |
| 12/31/2002 | US6500924 Package for using antagonists of the vitronectin receptor alpha-v beta3 comprising a metalloproteinase polypeptide of given amino acid sequence; treating arthritis, rheumatoid arthritis, retinopathy and tumors |
| 12/31/2002 | US6500868 Method for preventing and treating peripheral neuropathy by administering selegiline |
| 12/31/2002 | US6500867 Pharmaceutical composition comprising entacapone, levodopa, and carbidopa |
| 12/31/2002 | US6500866 1-(adamantyl)amidines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission |
| 12/31/2002 | US6500864 Disulfide derivatives useful for treating allergic diseases |
| 12/31/2002 | US6500863 Interleukin binding inhibitors such as n-(2-hydroxyl-3-amino sulfonyl-4-chlorophenyl)-n'-(2-bromophenyl)urea, used for prophylaxis of chemokine mediated diseases |
| 12/31/2002 | US6500862 Nonsettling mixtures of oleic, linoleic and palmitoleic acids, diethylene glycol, diethyl ether, n-methylpyrrolidone, polyethers, sodium laury sulfate, isopropanol, water and attractants having storage stability and chemical resistance |
| 12/31/2002 | US6500860 For inhibiting motility of sperm; for inducing destruction of testicular germ cells |
| 12/31/2002 | US6500859 Administering microtubule stabilizing chemotherapeutic agent for prophylaxis of arterial disease |
| 12/31/2002 | US6500857 Subcutaneous muscle treatment using electronic stimulation and topical compositions |
| 12/31/2002 | US6500856 For therapy of inflammatory diseases and other diseases involving elevated levels of cytokines and proinflammatory mediators |
| 12/31/2002 | US6500855 Nitrogen containing aromatic heterocycles with ortho-substituted p1 groups; anticoagulants |
| 12/31/2002 | US6500854 Chondrongenesis promotors and indolin-2-one derivatives |
| 12/31/2002 | US6500851 Antithrombotic agents |
| 12/31/2002 | US6500849 Administering antiinflammatory, antiproliferative, nootropic or antigrowth agents, such as 6-(1-dodecynyl)-2-pyridine-carboxaldehyde and enantiomorphs to mammals; alzheimers disease |
| 12/31/2002 | US6500847 Inhibition of matrix metalloproteases by substitued biaryl oxobutyric acids |
| 12/31/2002 | US6500846 2-(4-chlorophenyl)-7-methoxychromen-4-one, as cyclin-dependent kinase inhibitors, used as anticarcinogenic agents or for prophylaxis of neurodegenerative disease |
| 12/31/2002 | US6500845 Activating cytokine release using immunosuppressants such as 2-(3-methyl-2-oxo-piperidin-3-yl)-benzo(d)isoselenazol-3-one, racemic mixtures or isomers having dimensional stability, prepared in the presence of reducing agent |
| 12/31/2002 | US6500843 Inhibitors of rotamase enzyme activity |
| 12/31/2002 | US6500842 N-((4-chlorophenyl)methyl)-8-hydroxy-7-quinolinecarboxamide administered as viricides against herpes virus |
| 12/31/2002 | US6500841 Inhibitors of farnesyl-protein transferase |
| 12/31/2002 | US6500839 CRF receptor antagonists and methods relating thereto |
| 12/31/2002 | US6500838 Therapy for obsessive-complusive disorder |